CAP

Patheon to acquire Banner Pharmacaps

Tuesday, October 30, 2012 10:24 AM

Patheon, a Durham, N.C.-based provider of contract development and manufacturing services, has signed a definitive agreement with Vion, a global manufacturer of foodstuffs and ingredients based in the Netherlands, to acquire Banner Pharmacaps, a High Point, N.C.-based specialty pharmaceutical business dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

More... »

Venture capital investments decline in dollars and deal volume in Q3 2012

Friday, October 19, 2012 03:26 PM

Venture capitalists invested $6.5 billion in 890 deals in the third quarter of 2012, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters.

More... »

Longitude Capital closes second life sciences fund with $385M

Friday, October 12, 2012 12:13 PM

Longitude Capital has closed the Longitude Venture Partners II, a $385 million venture capital fund dedicated to investments in drug development and medical technology. 

More... »

Venture capital investment in life sciences down 9%

Friday, July 20, 2012 02:45 PM

Despite venture capitalists investing $7 billion in 898 deals in the second quarter of 2012—a 17% climb in terms of dollars and an 11% rise in the number of deals compared to the first quarter of 2012, when $6 billion was invested in 809 deals—the life sciences sector (biotechnology and medical devices) saw a 9% drop in funding dollars and a 6% drop in deals from the prior quarter, to $1.4 billion going into 174 deals in Q2.

According to the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters, the total number of early stage deals reached the highest quarterly total since Q1 2001, with $2.1 billion going into 410 deals. That’s an 18% increase in dollars and a 28% increase in deals from the prior quarter. Overall, the software industry took in the highest level of funding of all industries with $2.3 billion invested in Q2, the highest investment total for the sector since the Q2 2001.

More... »

Quotient Clinical, Capsugel collaborate on lipid-based formulations

Friday, June 29, 2012 11:23 AM

Quotient Clinical, a U.K. provider of specialist early stage drug development services, and Capsugel, a Morristown, N.J.-based provider of dosage solutions for the healthcare industry, have formed a collaboration to enable the rapid development and clinical assessment of lipid-based formulations. Together, the companies will use their technology and expertise to address the drug delivery challenges of poorly soluble molecules with limited oral bioavailability.

More... »

Teralys Capital, Lilly invest in new $150 million fund for life sciences

Wednesday, May 30, 2012 10:36 AM

Teralys Capital has invested $65 million, along with other amounts from Eli Lilly and other partners, in TVM Life Science Ventures VII, which closed on an initial size of $150 million.

More... »

Life Sciences venture capital investing falls in first quarter

Tuesday, April 24, 2012 12:21 PM

Venture capitalists invested $5.8 billion in 758 deals in the first quarter of 2012, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters. Quarterly venture capital (VC) investment activity fell 19% in terms of dollars and 15% in the number of deals compared to the fourth quarter of 2011, when $7.1 billion was invested in 889 deals.

More... »

Genstar Capital to acquire ERT

Tuesday, April 10, 2012 11:24 AM

Philadelphia-based eResearch Technology, a technology-driven provider of health outcomes research services to sponsors and CROs, has agreed to be acquired by affiliates of Genstar Capital, a middle market private equity firm, for $8 per share in cash in a transaction valued at approximately $400 million.

More... »

Arsenal Capital Partners acquires Western Institutional Review Board

Thursday, March 1, 2012 02:00 PM

Olympia, Wash.-based Western Institutional Review Board (WIRB), a privately held IRB, has been acquired by Arsenal Capital Partners, a New York-based private equity firm that invests in middle-market healthcare, specialty industrial and financial services companies.

More... »

Linden Capital Partners to acquire SeraCare for $82 million

Monday, February 13, 2012 03:08 PM

SeraCare Life Sciences, a global life sciences company, has agreed to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the healthcare and life science industries.

More... »